Apoptosis Induced by Niacin-Related Compounds in K562 Cells but not in Normal Human Lymphocytes.

DOI Web Site Web Site PubMed 被引用文献5件 参考文献20件
  • OGATA Shin
    Laboratory of Molecular and Cellular Biology, Department of Life Science, Faculty of Bioresources, Mie University
  • TAKEUCHI Masayo
    Laboratory of Molecular and Cellular Biology, Department of Life Science, Faculty of Bioresources, Mie University
  • FUJITA Hiroaki
    Laboratory of Molecular and Cellular Biology, Department of Life Science, Faculty of Bioresources, Mie University
  • SHIBATA Katsumi
    Course of Food Science and Nutrition, Department of Life Style Studies, School of Human Cultures, The University of Shiga Prefecture
  • OKUMURA Katsuzumi
    Laboratory of Molecular and Cellular Biology, Department of Life Science, Faculty of Bioresources, Mie University
  • TAGUCHI Hiroshi
    Laboratory of Molecular and Cellular Biology, Department of Life Science, Faculty of Bioresources, Mie University

この論文をさがす

説明

  In our previous study, we found that niacin-related compounds induced apoptosis in human acute myelomonocytic leukemia cells, HL-60. We have investigated whether these compounds acted as inducers of apoptosis also in various other cell types. In human chronic myelogenous leukemia cells, K562, which are relatively resistant to various inducers of apoptosis, the apoptosis was induced by picolinic acid and dipicolinic acid in about 50% of the cells 5-10 mM via the caspase pathway, but was not at 1 mM. However, isonicotinamide did not induce apoptosis effectively in K562 cells. On the other hand, in normal human quiescent lymphocytes, the apoptosis was not induced by these compounds at the same concentrations. It is suggested that these compounds may induce apoptosis mainly in tumor cells. The change of intracellular peroxide levels was observed in the early phase of apoptosis induced by niacin-related compounds. We expect to make use of niacin-related compounds in the field of medicine.<br>

収録刊行物

被引用文献 (5)*注記

もっと見る

参考文献 (20)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ